|
1
|
Gallamini A, Rambaldi A, Patti C, Romano A, Viviani S, Bolis S, Oppi S, Trentin L, Cantonetti M, Sorasio R, Gavarotti P, Gottardi D, Schiavotto C, Battistini R, Gini G, Ferreri A, Pavoni C, Bergesio F, Ficola U, Guerra L, Chauvie S. BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.19_2879] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A Gallamini
- Antoine Lacassagne Cancer Center Research and Clinical Innovation Nice France
| | - A Rambaldi
- Ospedale Papa Giovanni XXIII Hematology Bergamo Italy
| | - C Patti
- Ospedali Riuniti di Palermo Hematology Palermo Italy
| | - A Romano
- Policlinico Universitario A. Ferrarotto Hematology Catania Italy
| | - S Viviani
- Istituto Europeo di Ematologia Hematology Milano Italy
| | - S Bolis
- Ospedale S. Gerardo Hematology Monza Italy
| | - S Oppi
- Ospedale Antonio Businco Hematology Cagliari Italy
| | - L Trentin
- Azienda Ospedaliera di Padova Hematology Padova Italy
| | | | - R Sorasio
- Ospedale S. Croce e Carle Hematology Cuneo Italy
| | - P Gavarotti
- Ospedale S. Giovanni Battista Hematology ‐ University Torino Italy
| | - D Gottardi
- Ospedale Mauriziano Hematology Torino Italy
| | | | - R Battistini
- Ospedale S. Camillo Forlanini Hematology Roma Italy
| | - G Gini
- Ospedali Riuniti di Ancona Hematology Ancona Italy
| | | | - C Pavoni
- Ospedale Papa Giovanni XXIII Hematology Bergamo Italy
| | - F Bergesio
- Ospedale S. Croce e Carle Medical Physics Cuneo Italy
| | - U Ficola
- Ospedale La Maddalena Nuclear Medicine Palermo Italy
| | - L Guerra
- Ospedale S. Gerardo Nuclear Medicine Monza Italy
| | - S Chauvie
- Ospedale S. Croce e Carle Medical Physics Cuneo Italy
| |
Collapse
|
|
2
|
Gallamini A, Schiano de Colella J, Viotti J, Bijou F, Rambaldi A, Perrot A, Patti C, Gastaud L, Sorasio R, Debaigt C, Schiappa R, Chamorey E, Viviani S, Thyss A. BRENTUXIMAB-VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST-LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL). Hematol Oncol 2019. [DOI: 10.1002/hon.101_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A. Gallamini
- Clinical Research and Innovation; A. Lacassagne Cancer Center; Nice France
| | | | - J. Viotti
- Département d'Epidemiologie; de Biostatistiques et des Données de Santé, Centre Antoine Lacassagne; Nice France
| | - F. Bijou
- Oncologie Médicale; Institut Bergonié; Bordeaux France
| | - A. Rambaldi
- Ematologia; Ospedale Papa Giovanni XXII; Bergamo Italy
| | - A. Perrot
- Service Hématologie et Médecine Interne; CHU Nancy-Brabois; Vandoeuvre Les Nancy France
| | - C. Patti
- Ematologia; Ospedali Riuniti Villa Sofia e Cervello; Palermo Italy
| | - L. Gastaud
- Département d'Oncologie Médicale; Centre Antoine Lacassagne; Nice France
| | - R. Sorasio
- Ematologia; Ospedale Sante Croce e Carle; Cuneo Italy
| | - C. Debaigt
- Clinical Research and Innovation; A. Lacassagne Cancer Center; Nice France
| | - R. Schiappa
- Département d'Epidemiologie; de Biostatistiques et des Données de Santé, Centre Antoine Lacassagne; Nice France
| | - E. Chamorey
- Département d'Epidemiologie; de Biostatistiques et des Données de Santé, Centre Antoine Lacassagne; Nice France
| | - S. Viviani
- Dipartimento di Oncologia Medica; Istituto Nazionale Dei Tumori; Milano Italy
| | - A. Thyss
- Département d'Oncologie Médicale; Centre Antoine Lacassagne; Nice France
| |
Collapse
|
|
3
|
Gallamini A, Bijou F, Viotti J, Rossi A, Perrot A, Patti C, Gastaud L, Sorasio R, Debaigt C, Chamorey E, Viviani S, Thyss A. BRENTUXIMAB-VEDOTIN AND BENDAMUSTINE IS A FEASIBLE AND EFFECTIVE DRUG COMBINATION AS FIRST-LINE TREATMENT OF HODGKIN LYMPHOMA IN THE ELDERLY (HALO TRIAL). Hematol Oncol 2017. [DOI: 10.1002/hon.2438_28] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A. Gallamini
- Research Innovation and statistics; Antoine Lacassagne Cancer Center; Nice France
| | - F. Bijou
- Hematologie; Institut Bergonié; Bordeaux France
| | - J. Viotti
- Unité de Epidemiologie et Biostatistique; Antoine Lacassagne Cancer Center; Nice France
| | - A. Rossi
- Hematology; Ospedale Papa Giovanni XXIII; Bergamo Italy
| | - A. Perrot
- Hematologie; CHU Nancy-Brabois; Nancy France
| | - C. Patti
- Ematologia; Ospedale V. Cervello e Villa Sofia; Palermo Italy
| | - L. Gastaud
- Hematologie Oncolologie; Antoine Lacassagne Cancer Center; Nice France
| | - R. Sorasio
- Ematologia; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - C. Debaigt
- Research Innovation and statistics; Antoine Lacassagne Cancer Center; Nice France
| | - E. Chamorey
- Unité de Epidemiologie et Biostatistique; Antoine Lacassagne Cancer Center; Nice France
| | - S. Viviani
- Ematologia e trapianto MO; Istituto Nazionale Tumori; Milan Italy
| | - A. Thyss
- Hematologie Oncolologie; Antoine Lacassagne Cancer Center; Nice France
| |
Collapse
|
|
4
|
Gallamini A, Biggi A, Chauvie S, Bianchi A, Conti S, Fiore F, Sorasio R, Vose J, Thomas DL, Juweid ME. Does a negative post-therapy PET obviate the need for any further follow-up imaging in patients with nonbulky early-stage Hodgkin's lymphoma (HL)? J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|